Insights On Outsourced Drug Development

  1. Inside Bioprocessing: Microbial Media 11/4/2025

    Learn the reasons why the animal origin-free trend in bioprocessing has taken so long to reach microbial bioproduction and the technical hurdles overcome during the development of Gibco CD Bacto Supreme.

  2. Overcoming Excipient Risks And Challenges For Parenteral Formulations 8/27/2025

    Excipients are essential to parenteral formulations, which help protect APIs, enhance stability, and ensure safety. Learn how strategic excipient selection can optimize drug performance and patient outcomes.

  3. ddPCR Workflows For Gene Expression Analysis 3/5/2026

    RT-ddPCR offers a powerful, flexible approach to precise RNA quantification. Learn how one-step and two-step workflows improve sensitivity and efficiency in your gene expression studies.

  4. Walk-Away Monitoring Of Cytotoxicity, Viability, And Apoptosis 10/29/2025

    Real-time cell health monitoring reveals how drug dose and timing impact apoptosis, necrosis, and viability. Explore how automated workflows help pinpoint mechanistic toxicity windows.

  5. What Is A Viral Vector? 4/16/2024

    Review a novel adenovirus production process that offers scalable, single-use equipment-compatible solutions, reducing production time and cross-contamination risks.

  6. Rapid Walkaway Solution For Assessing Viability In Cancer Organoids 3/31/2025

    Assess anti-cancer compounds' effects on organoid size and morphology with colorectal cancer organoids as well as discover automated imaging and viability assays to streamline drug screening and aid early identification.

  7. VEGF Signaling Pathway 3/24/2025

    In Alzheimer's disease, reduced VEGF levels are linked to neurodegeneration, which can offer therapeutic potential. Discover how experimental treatments show promise in reducing memory impairment and beta-amyloid deposition.

  8. Modifying The Micro-Environment To Improve Dissolution Rate 6/11/2025

    Discover how modifying the micro-environment with targeted excipients can significantly enhance the dissolution rate of poorly soluble drugs using conventional manufacturing methods.

  9. Leveraging Optimized Transient Expression For Material Generation And Early Stage Insight 7/23/2024

    By using an optimized transient transfection platform, drug developers can accelerate their characterization and early development activities, facilitating continuity for a drug's scale-up.

  10. Highly Sensitive ELISAs In 90 Minutes 9/11/2024

    Traditional ELISA methods are often limited by their relatively low throughput and need for multiple wash steps. Learn about a solution that overcomes these challenges and provides rapid results.